Klaassen, Zachary, et al. “Contemporary Cost-Consequence Analysis of Blue Light Cystoscopy With Hexaminolevulinate in Non-Muscle-Invasive Bladder Cancer”. Canadian Urological Association Journal, vol. 11, no. 6, June 2017, pp. 173-81, doi:10.5489/cuaj.4568.